Drug
Olmesartan Medoxomil clinical trials
Also written Benicar and Olmetec.
Keep track of what changes. Save the Olmesartan Medoxomil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
- Azor
- 1
Studies by the year they started
43 studies that test it; most in 2005 (10)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 10 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 36 · Other 9
Daiichi Sankyo (19) · Sankyo Pharma Gmbh (7) · Mylan Pharmaceuticals Inc (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · Daiichi Sankyo Co., Ltd. (2) · EMS (2) · Pharmtechnology LLC (1) · Virginia Polytechnic Institute and State University (1)
Often tested with
Tested in the same studies.
Amlodipine (9) · Hydrochlorothiazide (8) · Losartan (4) · Olmesartan (3) · Irbesartan (2) · Valsartan (2) · Telmisartan (2) · OLM 40MG (1)
Studies
Open first, then newest update. How each study uses Olmesartan Medoxomil is read from its arms, and is right about nine times in ten.
Testing it · 45
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Benicar
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnPhase 3EMSNCT02493322Written as Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnPhase 3EMSNCT02483936Written as Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649623Written as Olmesartan Medoxomil Tablets 40 mg
- Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648219Written as Olmesartan Medoxomil Tablets 40 mg
- A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established AtherosclerosisCompletedPhase 3Daiichi SankyoNCT00382213Written as Olmesartan medoxomil
- The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.CompletedPhase 1Pharmtechnology LLCNCT03951051Written as Olmesartan Medoxomil 40 mg
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedPhase 3Daiichi SankyoNCT00902538Written as Olmesartan medoxomil 40 mg - Amlodipine 10 mg
- Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedPhase 3Daiichi SankyoNCT00923091Written as olmesartan medoxomil + amlodipine
- Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCompletedPhase 3Daiichi SankyoNCT00649389Written as Olmesartan medoxomil
- A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedPhase 4Daiichi SankyoNCT00791258Written as amlodipine and olmesartan medoxomil tablets
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedPhase 3Daiichi SankyoNCT00430508Written as olmesartan medoxomil/hydrochlorothiazide tablets
- Amlodipine as add-on to Olmesartan in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220220Written as olmesartan medoxomil
- Olmesartan as an add-on to Amlodipine in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220233Written as olmesartan medoxomil
- Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCompletedPhase 3Daiichi SankyoNCT00185133Written as Olmesartan medoxomil
- Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedPhase 3Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT00676845Written as olmesartan medoxomil
- The Confirmatory Olmesartan Plaque Regression StudyTerminatedPhase 4Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT01132768Written as olmesartan medoxomil
- Angiotensin II Blockade and Inflammation in ObesityCompletedPhase 4Virginia Polytechnic Institute and State UniversityNCT01684748Written as Olmesartan medoxomil
- Lowering Blood Pressure in Primary Care in ViennaCompletedPhase 4Wilhelminenspital ViennaNCT02377661Written as Olmesartan medoxomil, amlodipine, hydrochlorothiazide
- An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesCompletedPhase 4Daiichi SankyoNCT00403481Written as olmesartan medoxomil
See all 45 studies that test Olmesartan Medoxomil →
Given in every arm · 2 — Olmesartan Medoxomil is usual care beside what is tested
- Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionCompletedPhase 3NovartisNCT00523744Written as Olmesartan medoxomil
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Olmesartan medoxomil
As the comparator · 8 — what is tested is compared with Olmesartan Medoxomil
- Study of CS-3150 Compared to Olmesartan in Patients With Essential HypertensionCompletedNot applicableDaiichi Sankyo Co., Ltd.NCT02848170Written as olmesartan medoxomil
- Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedPhase 3Lee's Pharmaceutical LimitedNCT02609490Written as Olmesartan medoxomil tablets
- Fimasartan Achieving SBP Target (FAST) StudyCompletedPhase 4Boryung Pharmaceutical Co., LtdNCT02495324Written as Olmesartan medoxomil
- Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT02407210Written as Olmesartan medoxomil
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedPhase 3TakedaNCT01309828Written as Olmesartan medoxomil and hydrochlorothiazide
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00996281Written as Olmesartan medoxomil and hydrochlorothiazide
- A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276CompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01493856Written as Olmetec
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedPhase 3TakedaNCT01033071Written as Olmesartan medoxomil and hydrochlorothiazide
Codes
What other systems call Olmesartan Medoxomil · ClinicalTrials.gg INT006516
- MeSH (NLM) D000068557Olmesartan MedoxomilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6M97XTV3HDOLMESARTAN MEDOXOMILConfirmed FDA, NLM, Wikidata
- RxNorm 118463Confirmed FDA, Wikidata
- Wikidata Q27888058olmesartan medoxomilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47640Olmesartan MedoxomilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068557 | Olmesartan Medoxomil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6M97XTV3HD | OLMESARTAN MEDOXOMIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 118463 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27888058 | olmesartan medoxomil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47640 | Olmesartan Medoxomil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.